Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride…
Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride Tablets
- Published
- 16 Apr 2025
- Units affected
- 3144 bottles, pack size: 100's Count
- Agency
- FDA
- Country
- United States
The hazard
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1
- Brand / company
- Zydus Pharmaceuticals (USA) Inc
- Codes / lots
- Lot #: Z400069, Exp.: 12/31/2025
- Distribution
- Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 16 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.